Iqvia Holdings Inc. (1IQV)
MTA
Closed
Aug 21, 2026
Day's Range
210.1052 wk Range
132.65Overview - 1IQV - Iqvia Holdings Inc.
Key Statistics
Valuation
Enterprise Value
43.51B
P/E (Trailing)
‪129.36‬
PEG Ratio
‪-200.50‬
Price / Sales (TTM)
‪2.15‬
Price / Book
‪6.92‬
EV / EBITDA
‪16.70‬
Profitability
Gross Margin
‪32.85%‬
Profit Margin
‪8.09%‬
Operating Margin
‪13.02%‬
Return on Assets
‪5.06%‬
Return on Equity
‪22.81%‬
Ownership
Shares Outstanding
164.60M
Float
156.24M
Held by Insiders
‪1.08%‬
Held by Institutions
‪103.39%‬
Price stats
Beta
‪1.17‬
50-Day Avg
‪182.16‬
200-Day Avg
‪172.14‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1IQV - Iqvia Holdings Inc.
Peers - 1IQV - Iqvia Holdings Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on MTA.
Profile Summary - 1IQV - Iqvia Holdings Inc.
About
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The company supports pharmaceutical, biotechnology, medical device, and healthcare organizations in developing, testing, and commercializing therapies using extensive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
